Table 2 Group A (Orchidectomy) lipid profile data
From: The impact of androgen deprivation therapy on the lipid profile in patients with prostate carcinoma
Baseline(A) | 6 month(B) | 12 month(C)* | 24 month(D)* | p value | |
|---|---|---|---|---|---|
Total cholesterol | 180.6 ± 19.8 | 195.7 ± 28.3 | 189.4 ± 24.6 | 189.1 ± 24.5 | 0.14 |
Triglycerides | 103.1 ± 29.8 | 111.1 ± 28.7 | 112.1 ± 29.2 | 112.5 ± 29.6 | 0.57 |
HDL-cholesterol | 48.5 ± 7.9 | 50.5 ± 6.3 | 49.5 ± 6.4 | 48.9 ± 6.3 | 0.70 |
LDL-cholesterol | 111.4 ± 19.4 | 124.3 ± 26.5 | 119.4 ± 22.7 | 119.8 ± 21.9 | 0.19 |
VLDL-cholesterol | 20.2 ± 3.8 | 20.8 ± 2.8 | 20.5 ± 2.7 | 20.6 ± 2.5 | 0.87 |